J&J’s Kenvo deal may be very popular. What happens if it is.
font size
Johnson & Johnson took consumer health company Kenvue public in May.
Mark Ralston / Getty Images
Johnson and Johnson
‘s
$40 billion stock exchange offer
Kinfu
It is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to swap only a portion of their J&J stock.
Johnson and Johnson (stock ticker: JNJ) is offering its owners the opportunity to exchange their stock for Kenvue (KVUE) at a 7% discount to Kenvue’s market price. This incentive appears to be attracting strong demand from retail and institutional owners, as well as Wall Street auditors.
Index investors have a reason to get involved because Kenvue will be added to the
S&P 500 index
Shortly after the exchange offer ended on Friday. Show was It was unveiled on July 24.
like Barron Reported Monday Retail investors may need to instruct their brokerages before Friday Fidelity and Merrill have set deadlines for Thursday, though Fidelity will offer to make the exchange on a best efforts basis for orders received by mid-afternoon Friday . The deadline for Schwab’s retail sale was Monday.
J&J holders can choose to exchange all, some, or no shares of their shares for Kenvue. If they do nothing, they will keep their shares of J&J.
The current bet is that the offering will be oversubscribed and the percentage will be around 30%, meaning that J&J holders who choose to participate in the deal will receive only 30% of their shares converted into Kenvue shares. The swap will be tax free for J&J holders.
Kenvue owns J&J in the consumer health space, led by brands like Listerine, Band-Aid, and Tylenol. It was released to the public by J&J in May.
Wall Street trading desks put out estimates on proportionality and the consensus appears to be around 30%, consistent with the proportional distribution on
General Electric
(GE) exchange offer for
Financial synchronization
in 2015.
Shares of Johnson & Johnson fell 0.3% on Tuesday, to $172.94, while Kinvo shares were up 1.4%, at $23.26.
The three-day pricing period started on Monday and will end on Wednesday. Based on trading activity on Monday and Tuesday, J&J holders should receive approximately eight shares of Kenvue for every J&J share, or about $186 per share of J&J stock.
J&J provides an update on the show on a web site. There is also a file Question and Answer for investors and a A long S-4 document From Kenvue that defines the bargain.
J&J is scheduled to announce the swap ratio on Thursday based on the volume-weighted average stock prices from Monday through Wednesday.
J&J plans to swap 1.5 billion shares of Kenvue stock for its own shares in what amounts to a massive share buyback. The total offer could reach 1.7 billion Kenvue shares, or about 90% of the shares outstanding. Wall Street expects the entire amount to be exchanged, resulting in the retirement of about 8% of J&J shares.
One wrinkle is that J&J will issue no more than approximately 8.05 Kenvue shares for every J&J share. If the ratio rises above 8.05 based on the stock prices of the two companies, J&J investors will receive a discount of less than 7%. Based on trading activity on Monday and Tuesday, the ratio should be close to 8.05. If the cap is not breached, J&J holders will receive approximately $107.50 in Kenvue stock for $100 in J&J stock.
One potential reward for bid participants is that Kenvue stock is down nearly 5% since the exchange offer was revealed in July, due in part to arbitrage pressures. Arbs bought J&J and shorted Kenvue to take over the spread.
City
Analyst Filpo Vallorni wrote in a note on Tuesday that he expects Kinfo may rally once the exchange offering expires.
“KVUE shares were pressured by event-driven funds during the tender-exchange period and we expect additional volatility during the middle period (8/14-16) and on 8/21-22 as event-driven funds adjust positions post-close. We expect KVUE to outperform in “The following weeks, as shares will return to trading based on fundamentals. In addition, we expect a tailwind from index fund demand for KVUE shares following S&P Global’s announcement last week that the company will be added to the S&P 500 after the completion of the exchange offering period.”
He has a price target of $26 per share.
Kenvue now trades at about 18 times expected 2023 earnings per share and yields 3.5%. J&J brings in about 16x expected earnings for 2023 and yields 2.7%.
J&J holders of “single lots” of 99 shares or less who agree to exchange all of their shares will be able to fully participate in the offering and will not be prorated. This seems like a suitable setup for retail investors, such as Barron I mentioned recently.
Write to Andrew Bary at andrew.bary@barrons.com
